What Is VIP?
A 28-residue neuropeptide of the secretin/glucagon superfamily. It signals through the class II G-protein-coupled receptors VPAC1 and VPAC2, activating adenylate cyclase to raise cAMP and downstream PKA signaling.
⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.

Cellular Peptide
A 28-residue neuropeptide of the secretin/glucagon superfamily. It signals through the class II G-protein-coupled receptors VPAC1 and VPAC2, activating adenylate cyclase to raise cAMP and downstream PKA signaling. Premium Research Peptide
Technical specifications
A 28-residue neuropeptide of the secretin/glucagon superfamily. It signals through the class II G-protein-coupled receptors VPAC1 and VPAC2, activating adenylate cyclase to raise cAMP and downstream PKA signaling.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Immunomodulatory research compounds